Literature DB >> 16525648

Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.

Kazutaka Kurokohchi1, Tsutomu Masaki, Seishiro Watanabe, Seiji Nakai, Akihiro Deguchi, Asahiro Morishita, Hirohito Yoneyama, Tomohiro Ohgi, Masahiro Ono, Akira Yoshitake, Takeshi Kako, Naoko Ohmachi, Takaaki Kiuchi, Tsuyoshi Maeta, Mitsuo Yoshida, Yoshihiro Mori, Fumikazu Kohi, Shigeki Kuriyama.   

Abstract

We have previously reported that the combination therapy of percutaneous ethanol injection and radiofrequency ablation (PEI-RFA) was more effective than RFA alone to induce wider coagulated necrosis for the treatment of hepatocellular carcinoma (HCC). In the present study, the effect of time-lag performance of RFA after PEI was evaluated under the same ablation condition as PEI-RFA by analyzing the volume of coagulated necrosis, the energy requirement for ablation and the amount of ethanol injected into HCC. The comparative study between time-lag PEI-RFA and no time-lag PEI-RFA showed that the total energy requirement and the energy requirement per unit volume for whole and marginal coagulated necrosis were significantly smaller in the time-lag group than in the no time-lag PEI-RFA group. In time-lag PEI-RFA, the volume of coagulated necrosis induced positively correlated with the amount of ethanol injected into HCC as previously observed in PEI-RFA treatment. These results suggest that time-lag PEI-RFA can induce comparable coagulated necrosis with a smaller energy requirement than no time-lag PEI-RFA, and that time-lag PEI-RFA is likely to be less invasive than no time-lag PEI-RFA for inducing comparable coagulated necrosis. Thus, time-lag performance of RFA after PEI may make RFA treatment more effective and less invasive for the treatment of patients with HCC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16525648

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

Review 1.  Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.

Authors:  Lumin Chen; Jihong Sun; Xiaoming Yang
Journal:  Cancer Lett       Date:  2015-10-22       Impact factor: 8.679

2.  Considerations for two inoculation methods of rabbit hepatic tumors: Pathology and image features.

Authors:  Jun-Hui Sun; Yue-Lin Zhang; Chun-Hui Nie; Xiao-Bo Yu; Hai-Yang Xie; Lin Zhou; Shu-Sen Zheng
Journal:  Exp Ther Med       Date:  2011-12-28       Impact factor: 2.447

3.  Successful treatment of hypovascular advanced hepatocellular carcinoma with lipiodol-targetting intervention radiology.

Authors:  Kazutaka Kurokohchi; Akihiro Deguchi; Tsutomu Masaki; Takashi Himoto; Hirohito Yoneyama; Mitsuyoshi Kobayashi; Tsuyoshi Maeta; Takaaki Kiuchi; Fumikazu Kohi; Hisaaki Miyoshi; Tomohiko Taminato; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2007-08-28       Impact factor: 5.742

4.  A combination therapy of ethanol injection and radiofrequency ablation under general anesthesia for the treatment of hepatocellular carcinoma.

Authors:  Kazutaka Kurokohchi; Seishiro Watanabe; Hirohito Yoneyama; Akihiro Deguchi; Tsutomu Masaki; Takashi Himoto; Hisaaki Miyoshi; Hamdy-Saad Mohammad; Akira Kitanaka; Tomohiko Taminato; Shigeki Kuriyama
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

5.  Recent advances in radiofrequency ablation for the management of hepatocellular carcinoma.

Authors:  Takashi Himoto; Kazutaka Kurokohchi; Seishiro Watanabe; Tsutomu Masaki
Journal:  Hepat Mon       Date:  2012-10-10       Impact factor: 0.660

6.  Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma.

Authors:  Naveen Kalra; Mandeep Kang; Ajay K Duseja; Anmol Bhatia; Virendra Singh; Radha K Dhiman; Arvind Rajwanshi; Yogesh K Chawla; Niranjan Khandelwal
Journal:  Indian J Med Res       Date:  2017-11       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.